Oncology NEWS International Vol 19 No 3

Final-Phase Trial Underway for Everolimus in Gastric Cancer

March 18, 2010

Pretreated patients with metastatic gastric cancer experienced a boost in overall survival after treatment with everolimus (Afinitor), according to the results of a phase II trial presented at the 2010 Gastrointestinal Cancers Symposium.

Genetic variations influence statin efficacy for lowering colon cancer risk

March 18, 2010

Four years ago, at least five years of statin use was found to be associated with a 53% reduction in the risk of colorectal cancer and that association still stands, according to a coauthor of one of the initial studies to make the statin-cancer connection.

Single-shot Zevalin presents new lymphoma Rx option

March 18, 2010

Unlike conventional radiation, Yttrium-90-ibritumomab tiuxetan (Zevalin) induces cellular damage only in the targeted tumor cells and has demonstrated activity in follicular and diffuse large B-cell non-Hodgkin’s lymphoma.

Who's News

March 16, 2010

A $450,000 grant from the Damon Runyon Cancer Research Foundation has been awarded to Heather Christofk, PhD. Read more about the latest awards and appointments in the cancer care community.